Johnson & Johnson's (JNJ) Wins $1.67B Patent Verdict Versus Abbott Laboratories (ABT)

June 30, 2009 7:20 AM EDT

Centocor Ortho Biotech Inc., wholly-owned subsidiary of Johnson & Johnson (NYSE: JNJ), announced that a federal jury has returned a verdict of $1.67 billion against Abbott Laboratories (NYSE: ABT) in a patent infringement suit.

The patent in question relates to the company's anti-TNF class of arthritis treatments, and is co-owned by New York University and Centocor, for which Centocor is the exclusive licensee.


Related Categories

Corporate News
Hot List

Stocks Mentioned

ABT 55.11

-0.15 -0.27%
Volume: 5,506,961
Track ABT

JNJ 64.60

-0.29 -0.45%
Volume: 13,954,803
Track JNJ


Related Entities


Add Your Comment





Follow StreetInsider.com On Twitter